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Cardiac arrest is a leading cause of death in the devel-
oped world. In the US, more than 500,000 patients die
from a cardiac arrest every year [1]. The public health
impact of cardiac arrest in the UK is also quite substan-
tial [2]. While mortality is high, even those who survive
a cardiac arrest are at a significant risk of permanent
neurological damage. Thus, improving survival and
reducing neurological disability is a fundamental goal of
patient care and a priority for public health.
Conceptually, mortality in cardiac arrest occurs in two
distinct phases. Patients either die acutely due to a
failure to attain return of spontaneous circulation
(ROSC), which depends on timely, high-quality resusci-
tation, or, alternatively, they die following ROSC due to
a cascade of clinical events, which may depend on inva-
sive treatments, quality of nursing, and critical care
(post-resuscitation phase). In recent years, the post-
resuscitation phase has been recognized as an important
phase of resuscitation. The European Resuscitation
Council and the American Heart Association have pub-
lished guidelines emphasizing treatment strategies for
optimizing post-resuscitation care, which includes early
coronary angiography, targeted temperature management
(TTM), close monitoring and treatment in intensive care
unit (ICU), delaying neurological prognostication, and
regionalizing care [3, 4]. In its recent report Strategies to
Improve Cardiac Arrest Survival the Institute of Medicine
included improving systems of resuscitation care
within hospitals as a key recommendation to improve
outcomes [5].
In the current issue of Critical Care, Professor Nolan
and colleagues provide interesting new data regarding
temporal patterns of post-resuscitation management and
outcomes in the UK. Using data from a national ICU
audit, 63,417 patients across 286 ICUs who had received
cardiopulmonary resuscitation and mechanical ventila-
tion within 24 h were included. A substantial reduction
in in-hospital mortality over an 11-year period was
noted—both in patients with out-of-hospital cardiac ar-
rest (OHCA: 70.1 % in 2004 to 66.4 % in 2014; risk-
adjusted odds ratio [OR] per year 0.96; 95 % confidence
interval [95 % CI] 0.95–0.97, P value for trend <0.001) and
in-hospital cardiac arrest (IHCA: 70.4 % in 2004 to 60.3 %
in 2014; risk-adjusted OR per year 0.96, 95 % CI 0.95–
0.97, P value for trend <0.001). Risk adjustment in the
study was performed using a validated hierarchical model
that accounted for case mix and within-ICU clustering. A
decline in post-cardiac arrest mortality was accompanied
by an increase in use of therapeutic hypothermia, indir-
ectly measured as the lowest temperature of <34 °C and
avoidance of early treatment withdrawal. The rate of organ
donation among non-survivors also increased threefold
(3.1 % in 2004 to 10.1 % in 2014), providing a needed im-
petus to the low rates of organ donation in the UK [6].
The study has a few limitations, many of which were
acknowledged by the authors. First, although large and
comprehensive, data collection was not based on the
Utstein template and important variables, such as initial
rhythm, were not available. Given that cardiac arrests
due to ventricular rhythms, which are associated with
significantly better survival, have declined in recent years
[7, 8], it is possible that the survival trends noted in the
current study are even more pronounced. Second, data on
neurological function in survivors were also not available,
which makes it difficult to assess whether the substantial
improvement in survival was clinically meaningful.
Third, patients who experienced IHCA while already
admitted and receiving care in an ICU were not
included, a group that comprises over 50 % of IHCA
cases in the US [8].
Despite the above limitations, Nolan and colleagues
need to be congratulated for providing detailed informa-
tion regarding post-cardiac arrest outcomes in a large
cohort of patients in the UK. Their findings add to a
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growing body of literature that has shown an unmistak-
able improvement in survival and neurological outcomes
for both OHCA and IHCA [8, 9]. Such data challenge
the existing nihilism associated with resuscitation and
can potentially invigorate research and quality improve-
ment efforts to ensure that improved outcomes are
sustained over time.
So, what is the mechanism of mortality reduction noted
in this study? The authors attributed it to increasing use of
hypothermia and delaying treatment withdrawal, strategies
emphasized in the guidelines [3, 4]. However, causal inter-
pretation is difficult due to the design of this study.
Although recommended in all comatose survivors of
cardiac arrest, the benefit of hypothermia has only been
demonstrated in patients with OHCA due to ventricular
rhythms [10, 11]. Among patients with asystole or pulseless
electrical activity, or patients with IHCA, the benefit of
hypothermia is not proven [12]. Moreover, even among
patients with OHCA, recent data from the TTM trial have
shown that cooling to 36 °C provided the same benefit as
more intensive cooling to 33 °C [13].
Accurate timing of neurological prognostication also re-
mains a challenge in clinical practice. Current guidelines
recommend delaying neurological prognostication for 72 h
or longer after achieving normothermia to avoid premature
treatment withdrawal. Over the study period, there was a
notable increase in the median time between cardiac arrest
and time of treatment withdrawal from 2.5 to 3.3 days.
While data were not stratified by hypothermia treat-
ment, it is conceivable that early withdrawal of care
before the recommended time period does occur in
some patients. However, this reflects the reality of
clinical practice where physicians must balance the
risk of providing care that is perceived as unnecessary
or futile with the risk of premature withdrawal while
managing expectations of family members and respecting
patients’ stated wishes.
Although the above trends in hypothermia and timing
of care withdrawal are noteworthy, it isn’t clear whether
they are the sole drivers of survival improvement. Post-
resuscitation survival depends on a multitude of factors,
such as timely provision of life-saving treatments, multi-
disciplinary teams, comprehensive critical/nursing care,
and continuous quality improvement, all of which are
enabled by institutional expertise, resources, and leader-
ship. An important next step may be to examine site-level
variation in survival to identify sites that consistently
achieve exceptional post-cardiac arrest outcomes [14].
Identifying and evaluating processes employed by such
outlier sites, using a combination of quantitative and
qualitative methods could help identify best practices for
post-resuscitation care [15]. Implementation of best prac-
tices across sites could ensure that the survival trends
noted in this study are sustained over time.
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